Screener
Vor Biopharma VOR Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Vor Biopharma’s reported figures.
Based on the most recent quarter.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
FAQ
- What is Vor Biopharma's current ratio?
- Vor Biopharma (VOR) reported current ratio of 31.1× in Q1 2026.
- How has Vor Biopharma's current ratio changed year-over-year?
- Vor Biopharma's current ratio increased by 703.5% year-over-year, from 3.9× to 31.1×.
- What is the long-term trend for Vor Biopharma's current ratio?
- Over 5 years (2020 to 2025), Vor Biopharma's current ratio has grown at a 30.5% compound annual growth rate (CAGR), from 4.8× to 18.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Vor Biopharma's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude